************* ************* PROGRESS NOTE  Assessment and Plan:      Exam Date: **/**/****  Patient:****** * ****** ** (********)   Impression:  Refractile plaque OD inferior macula noted */****, appears extra vascular  -- may simply be a cholesterol exudate or refractile drusen.    -- Carotid ** */**** - >50% stenosis OU      Glaucomatous optic atrophy with Visual field defect OD > OS.  Optic nerves on exam do not appear frankly glaucomatous, however, screening FDT by Dr. ****** shows progressive field loss, and *** show thinning of the optic nerve fiber layer in a corresponding pattern.  There is no edema, unusual vessels to suggest other etiology such as compression, ischemia.  Mild pallor vs ************ to monitor.  Visual field pattern is not consistent with neurologic pattern.  Optic nerve can weaken after retina surgery, but would not necessarily expect progressive loss. Macula has distorted anatomy OD which is longstanding.  Denies risk factor for tob-EtOH amblyopia.     - IOP max 19+, 18 off drops  - HVF */**/**** (may be consistent with macular changes after ERM surgery) - dense SAD OD, inferior defects OS, corresponding to prior FDT, **/*/****.*/**/**** very slightly worse OD, */**/**** - OD paracentral defect (does not correlate to ON), OS stable, */*/****, **/****- stable  - *** ** and Macula - */*/**** - thinning of NFL **, */**/****, */**/****, */**/****, */*/****  - stable, **/**/**** mild changes OD   - */**/**** start Latanoprost OU qhs, */**/**** - stable   - CCT  : RE- 584; LE- 584  - start Latanoprost qHS ** */**/**** - good response   -- IOP **-** **,**-**, LE on latanoprost qHS OU        Diabetes mellitus vs prediabetes with mild nonproliferative diabetic retinopathy.  -- *** and **** Hemorrhage OD periphery.  I discussed the effects of elevated glucose on the eye, and the importance of strict control of vasculopathic risk factors in preventing progression of retinopathy.        Pseudophakia OD - doing well, still with washed out colors and metamorphopsia OD, possibly due to h/o ERM/s/p PPV.  -- S/p Phaco/IOL OD */**/**** ***** 18.5 *** (***, distance goal)      ERM OD - pt seeing metamorphopsia   -- S/p PPV/MP/AFX OD, */**/****       Cataract OS - continue to monitor      Optometrist: Dr. *******, for comprehensive care      Plan: Continue Latanoprost qhs OU  RTC 6 months DFE with HVF and *** **    Physician: ******* * ********, MD     **/**/****       HPI: ****** * ****** ** (********), 68 y.o. year old male  from ******** : Patient presents with:  Medical Eye Examination    The patient states vision doing well, stable. No pain or discomfort.    Latanoprost QHS OU    MD history: No complaints. Feeling stable without change.    Appt notes at time of scheduling:   *no copay 4 mos Med F/up DFE + HVF 24-2 ***/**/** pt r/s bj  Medicare A&B/**** ******* - Cad    Primary Care Provider: ****** *********, MD  Past ocular history:  Pseudophakia OD  -- S/p Phaco/IOL OD */**/**** ***** 18.5 *** (***, distance goal)  ERM OD  -PPV/MP/AFX right eye **/**/****       Medications:   Current Outpatient Medications   Medication Sig   • aspirin EC 81 mg oral tablet,delayed release (DR/EC) Take  by mouth once daily in the morning.   • latanoprost 0.005 % ophthalmic (eye) drops INSTILL ONE **** INTO EACH EYE NIGHTLY AT BEDTIME   • lisinopril 5 mg oral tablet Take 5 mg by mouth once daily.   • metFORMIN 250 MG oral tablet Take 250 mg by mouth two times daily.   • *****-3 Fatty Acids 500 mg oral capsule Take  by mouth two times daily.   • simvastatin 20 mg oral tablet Take 20 mg by mouth once daily in the evening.     No current facility-administered medications for this visit.         Medical history/PMH/Review of systems:   Patient Active Problem List   Diagnosis   • Coronary arteriosclerosis in native artery   • Dyslipidemia   • Essential hypertension   • Epiretinal membrane (ERM) of right eye   • Diabetes mellitus type 2 without retinopathy (HCC)   • Glaucomatous optic atrophy of both eyes     Past Medical History:   Diagnosis Date   • Borderline diabetic    • Cataract    • Heart disease    • High cholesterol    • Hypertension    • Type 2 diabetes mellitus (HCC)         Allergies: has No Known Allergies.       has a past surgical history that includes knee scope with removal of cartilage from knee joint; placement of lad coronary artery stent (2010); heel spur surgery; lumbar laminectomy; rotator cuff repair (Right); and cataract removal with implant (Right, */**/**).   Reviewed systems for: fever, wt. loss, ENT, cardiovascular, pulmonary, GI, urinary, neurologic, endocrine, bleeding/blood disorders, AIDS/HIV, cancer/tumors, arthritis - all were negative except as noted above.         Family ocular history:   See scanned intake form or preadmission data in EPIC for full Family ocular and medical history.       Tobacco use:  reports that he has never smoked. He has never used smokeless tobacco.     EXAMINATION:    Not recorded           (procedure note or additional testing results if applicable):  N/A    See EPIC ophthalmology module for exam information.      Assessment and Plan is now at the top of the note.   I am ******** ****** functioning as a scribe for ******* * ********, MD at 1:31 PM on **/**/****      (MD sig): I have reviewed and verified the above scribed note of my visit with this patient as recorded by ******** ******.  I have reviewed and edited history and technician documentation, and performed all other elements to above examination documentation.  The attending physician is responsible for and agrees with the entire content of the note and has personally performed the HPI and the physical examination.      ******* ********, MD  ********* *********  ************* *************  ***** *** *********  **** ** **** ***, **** *****  ********, **  *****  (***) ***-****      Physician: ******* * ********, MD    